Results 111 to 120 of about 126,231 (300)
Propranolol Treatment in the Management of Infantile Hemangioma in Erbil, Iraq [PDF]
Iranian Journal of NeonatologyBackground: Infantile hemangioma is a common benign vascular tumor that affects up to 10% of infants. Propranolol, a beta-blocker, has been used as a promising treatment for infantile hemangioma, but its effectiveness remains controversial.
Wesam Boya Kaka +2 more
doaj +1 more source
Clinical Case Reports, Volume 13, Issue 2, February 2025.ABSTRACT Percutaneous sclerotherapy with bleomycin is an effective, minimally invasive treatment for aggressive pediatric hemangiomas, especially when traditional therapies fail. This approach can improve clinical outcomes, including thrombocytopenia resolution and tumor size reduction, with minimal systemic side effects.
Iman Kiani +4 more
wiley +1 more source
American Journal of Medical Genetics Part A, Volume 197, Issue 1, January 2025.ABSTRACT We studied three brothers and a maternal half‐brother featuring global developmental delay, mild to moderate intellectual disability, epilepsy, microcephaly, and strabismus. All had bilateral perisylvian and perirolandic polymicrogyria, while some also had malformations of the hippocampus (malrotation and dysplasia), cerebellum (heterotopias ...
Naomi Laflamme +9 more
wiley +1 more source
Treatment With Propranolol for Infantile Hemangioma in 13 Taiwanese Newborns and Young Infants
Pediatrics and Neonatology, 2012 Hemangioma in infants has a benign self-limited course, but the 10% of cases with complications need further treatment. Successful treatment with propranolol in western countries has been reported over the past few years.
Teng-Chin Hsu +6 more
doaj +1 more source
Hemangiomas. Novas Terapêuticas! [PDF]
, 2011 Introdução: Os hemangiomas constituem a neoplasia mais frequente na criança, ocorrendo em 10-12%, na maioria dos casos com evolução favorável. A fase proliferativa, ocorre nos primeiros 4-6 meses e depois involuem em 50% dos casos, até aos 5 anos.
Brito, MJ, Salva, I
core
Oral encapsulated vascular malformation: an undescribed presentation in the mouth [PDF]
, 2016 Vascular lesions have been classified in two broad categories, hemangiomas and malformations. Encapsulated vascular lesions have not been reported in the oral cavity, but they were described in other sites, mainly in the orbit.
Almeida, Oslei Paes de +5 more
core +2 more sources
Cerebral Cavernous Malformation: From Genetics to Pharmacotherapy
Brain and Behavior, Volume 15, Issue 1, January 2025.CCM1, CCM2, CCM3, MAP3K3, and PIK3CA genes mediate CCM pathogenesis by regulating the RhoA–ROCK, MAP3K3–KLF2/4, and PIK3CA–AKT–mTOR pathways, affecting processes such as cell migration, intercellular junctions, cell proliferation, inflammation, autophagy, EndMT, angiogenesis, and oxidative stress.
Zhuangzhuang Zhang +3 more
wiley +1 more source
Topical timolol for small infantile hemangioma: a new therapy option
The Turkish Journal of Pediatrics, 2012 The main characteristic of infantile hemangioma is that it grows rapidly after birth and mostly regresses spontaneously. It is a common practice for only a small part of the hemangioma to be treated, as they can be extremely disfiguring and ...
Anne Weissenstein +3 more
doaj
Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas [PDF]
, 2018 Beta-blockers are a highly promising treatment modality for complicated infantile hemangiomas (IH). However, data on propranolol as first-line treatment, objective outcome measures and impact on hemodynamics in young infants is limited.
Balmer, Christian +7 more
core
The biker-glove pattern of congenital melanocytic nevi. [PDF]
, 2019 Congenital melanocytic nevi (CMN) are common birthmarks with 20% occurring on the limbs. We describe 4 patients with acral CMN with a "biker-glove" distribution with sparing of the distal digits, as has previously been described in acral infantile ...
Frieden, Ilona J +3 more
core +2 more sources